We also demonstrate enhanced effect of the combinations in vivo as assessed by survival times and tumor sizes in patient-derived orthotopic xenograft (PDX) mouse models of human GBM after treatment with anti-CD47 Ab combined with either irradiation or TMZ chemotherapy. This evidence concerns the gene CD47 and glioblastoma.